GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,541,000 | -20.4% | 4,398,909 | +5.9% | 0.00% | – |
| Q2 2016 | $1,935,000 | -66.1% | 4,152,105 | -1.1% | 0.00% | -100.0% |
| Q1 2016 | $5,709,000 | -4.1% | 4,198,008 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $5,954,000 | -4.9% | 4,050,423 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $6,261,000 | -12.2% | 3,962,727 | -5.6% | 0.00% | 0.0% |
| Q2 2015 | $7,135,000 | +20.7% | 4,197,001 | -1.3% | 0.00% | 0.0% |
| Q1 2015 | $5,912,000 | -4.1% | 4,253,438 | +4.2% | 0.00% | 0.0% |
| Q4 2014 | $6,162,000 | -24.8% | 4,080,551 | +2.6% | 0.00% | 0.0% |
| Q3 2014 | $8,196,000 | -30.4% | 3,978,641 | +3.4% | 0.00% | -50.0% |
| Q2 2014 | $11,778,000 | +29.8% | 3,848,978 | +6.1% | 0.00% | 0.0% |
| Q1 2014 | $9,071,000 | -48.0% | 3,628,533 | +3.2% | 0.00% | -33.3% |
| Q4 2013 | $17,433,000 | +109.0% | 3,514,797 | -4.0% | 0.00% | +50.0% |
| Q3 2013 | $8,343,000 | +34.6% | 3,659,353 | +31.1% | 0.00% | +100.0% |
| Q2 2013 | $6,198,000 | – | 2,791,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
| Thomasville National Bank | 95,000 | $195,000 | 0.08% |
| SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
| Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |